Senior Manager Facilities & Site Operations at Gilead Sciences

Tokyo, Japan

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Leadership and expertise in Facilities and Site Operations to support VP and Senior Leadership team in Japan
Experience managing operations in GMP environments
Ability to develop and execute real estate strategies aligned with business needs
Proficiency in project management, including capital projects, Leasehold Improvement, Churn, and Operational Excellence projects
Skills in managing third-party suppliers and service providers
Knowledge of buildings mechanical, electrical, health, safety, environmental, and security (M&E, EHS & Security)
Capability to ensure legal compliance for buildings, plant, equipment, and services across Japan
Experience in financial forecasting (3-year) and annual planning
Understanding of procurement, outsourcing, SLAs, and KPIs

Responsibilities

Lead, manage, and be accountable for Tokyo Depot project
Responsible for Depot Site Operations in GMP environment
Determine, develop, and execute CEF real estate strategy for material warehouses
Supervise Site Manager and Facilities Team to deliver efficient on-site services
Provide country leadership, supporting regional business and global F&O team
Manage FM teams to support country business needs
Collaborate with Space & Master planning and Project Teams on capital projects and workplace initiatives
Manage Leasehold Improvement, Churn, and Operational Excellence projects
Manage delivery of capital projects, including third-party suppliers
Develop annual country plan for site objectives and 3-year financial forecast
Develop hard and soft services strategy with appropriate SLAs and KPIs
Develop annual procurement program aligned to Facilities Master Plan
Strategize and execute optimized outsourcing solutions
Provide support and advice on buildings M&E, EHS, security, and Business Continuity Plan
Undertake regular technical reviews of M&E, EHS & Security, and Business Continuity Plan
Ensure legal compliance for all buildings, plant, equipment, and services across Japan
Provide technical advice on new project concepts, design standards, best practices, and risk management
Oversee EHS and Security operations for regulatory compliance and safe workplace
Create and enforce SOPs and policies to comply with company and local regulations

Skills

Facilities Management

Site Operations

Project Management

Real Estate Management

Vendor Management

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free